Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew E Hogan

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
Obesity (Silver Spring, Md.)|May 9, 2023
Glucagon-like peptide-1 therapy in people with obesity restores natural killer cell metabolism and effector functionConor De Barra, Mohammed Khalil, Arimin Mat, et al.
Clinical Immunology (Orlando, Fla.)|June 21, 2011
Cigarette smoke alters the invariant natural killer T cell function and may inhibit anti-tumor responsesAndrew E Hogan, Michelle A Corrigan, Vincent O'Reilly, et al.
Diabetologia|March 19, 2022
Mucosal-associated invariant T cells are associated with insulin resistance in childhood obesity, and disrupt insulin signalling via IL-17Ronan Bergin, David Kinlen, Nidhi Kedia-Mehta, et al.
Cellular & Molecular Immunology|February 29, 2020
Targeting mitochondrial dysfunction in MAIT cells limits IL-17 production in obesityAisling O' Brien, Nidhi Kedia-Mehta, Laura Tobin, et al.
Discovery Immunology|March 11, 2025
Obesity drives dysregulation in DC responses to viral infectionAndrea Woodcock, Ronan Bergin, Nidhi Kedia-Mehta, et al.
The Journal of Clinical Endocrinology and Metabolism|January 16, 2014
The impact of childhood obesity on inflammation, innate immune cell frequency, and metabolic microRNA expressionEirin Carolan, Andrew E Hogan, Michelle Corrigan, et al.
Cancer Immunology, Immunotherapy : CII|August 23, 2006
CD1 expression and CD1-restricted T cell activity in normal and tumour-bearing human liverTony Kenna, Margaret O'Brien, Andrew E Hogan, et al.
Obesity (Silver Spring, Md.)|August 22, 2024
GLP-1 therapy increases visceral adipose tissue metabolic activity: lessons from a randomized controlled trial in obstructive sleep apneaCliona O'Donnell, Odhrán Ryan, Andrew E Hogan, et al.
Plos One|December 17, 2011
Distinct and overlapping effector functions of expanded human CD4+, CD8α+ and CD4-CD8α- invariant natural killer T cellsVincent O'Reilly, Shijuan G Zeng, Gabriel Bricard, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 16, 2013
Human invariant NKT cell subsets differentially promote differentiation, antibody production, and T cell stimulation by B cells in vitroShijuan Grace Zeng, Yasmeen G Ghnewa, Vincent P O'Reilly, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Obesity (Silver Spring, Md.)|May 9, 2023
Glucagon-like peptide-1 therapy in people with obesity restores natural killer cell metabolism and effector functionConor De Barra, Mohammed Khalil, Arimin Mat, et al.
Clinical Immunology (Orlando, Fla.)|June 21, 2011
Cigarette smoke alters the invariant natural killer T cell function and may inhibit anti-tumor responsesAndrew E Hogan, Michelle A Corrigan, Vincent O'Reilly, et al.
Diabetologia|March 19, 2022
Mucosal-associated invariant T cells are associated with insulin resistance in childhood obesity, and disrupt insulin signalling via IL-17Ronan Bergin, David Kinlen, Nidhi Kedia-Mehta, et al.
Cellular & Molecular Immunology|February 29, 2020
Targeting mitochondrial dysfunction in MAIT cells limits IL-17 production in obesityAisling O' Brien, Nidhi Kedia-Mehta, Laura Tobin, et al.
Discovery Immunology|March 11, 2025
Obesity drives dysregulation in DC responses to viral infectionAndrea Woodcock, Ronan Bergin, Nidhi Kedia-Mehta, et al.
The Journal of Clinical Endocrinology and Metabolism|January 16, 2014
The impact of childhood obesity on inflammation, innate immune cell frequency, and metabolic microRNA expressionEirin Carolan, Andrew E Hogan, Michelle Corrigan, et al.
Cancer Immunology, Immunotherapy : CII|August 23, 2006
CD1 expression and CD1-restricted T cell activity in normal and tumour-bearing human liverTony Kenna, Margaret O'Brien, Andrew E Hogan, et al.
Obesity (Silver Spring, Md.)|August 22, 2024
GLP-1 therapy increases visceral adipose tissue metabolic activity: lessons from a randomized controlled trial in obstructive sleep apneaCliona O'Donnell, Odhrán Ryan, Andrew E Hogan, et al.
Plos One|December 17, 2011
Distinct and overlapping effector functions of expanded human CD4+, CD8α+ and CD4-CD8α- invariant natural killer T cellsVincent O'Reilly, Shijuan G Zeng, Gabriel Bricard, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 16, 2013
Human invariant NKT cell subsets differentially promote differentiation, antibody production, and T cell stimulation by B cells in vitroShijuan Grace Zeng, Yasmeen G Ghnewa, Vincent P O'Reilly, et al.
Pageof 7